SPRINGER TIMOTHY A Insider Trading Activity

Average Profitability
17.37%
Insider Buys Quantity
20
Insider Buys Sum
$18.06M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of SPRINGER TIMOTHY A

Biography of SPRINGER TIMOTHY A

No biography is available at this moment.

2025-04-11PurchaseCartesian Therapeutics, Inc.
RNAC
42,750
0.1758%
$10.77$460,529-13.03%
2025-04-11PurchaseTectonic Therapeutic, Inc.
TECX
63,184
0.2587%
$16.31$1.03M+29.21%
2025-04-10PurchaseCartesian Therapeutics, Inc.
RNAC
57,170
0.2285%
$10.47$598,524-10.42%
2025-04-10PurchaseTectonic Therapeutic, Inc.
TECX
53,950
0.2266%
$16.73$902,584+25.12%
2025-04-09PurchaseCartesian Therapeutics, Inc.
RNAC
49,155
0.1769%
$9.43$463,464-18.13%
2025-04-09PurchaseTectonic Therapeutic, Inc.
TECX
24,789
0.0918%
$14.76$365,900+23.87%
2025-04-07PurchaseTectonic Therapeutic, Inc.
TECX
500,000
2.1462%
$17.10$8.55M+33.77%
2025-03-20PurchaseCartesian Therapeutics, Inc.
RNAC
54,889
0.2073%
$15.59$855,593-38.86%
2025-03-19PurchaseCartesian Therapeutics, Inc.
RNAC
20,234
0.0762%
$14.97$302,962-36.93%
2025-03-18PurchaseCartesian Therapeutics, Inc.
RNAC
14,740
0.0562%
$14.42$212,599-33.15%
2025-02-05PurchaseTectonic Therapeutic, Inc.
TECX
789,294
10.0406%
$50.68$40M-56.18%
2025-01-14PurchaseCartesian Therapeutics, Inc.
RNAC
4,022
0.0156%
$18.00$72,396-42.34%
2025-01-13PurchaseCartesian Therapeutics, Inc.
RNAC
16,945
0.0631%
$17.35$293,958-43.21%
2024-12-23PurchaseCartesian Therapeutics, Inc.
RNAC
5,181
0.0201%
$19.00$98,437-44.83%
2024-12-20PurchaseCartesian Therapeutics, Inc.
RNAC
21,800
0.0839%
$18.94$412,968-43.43%
2024-12-19PurchaseCartesian Therapeutics, Inc.
RNAC
3,376
0.0126%
$18.93$63,901-44.14%
2024-12-19PurchaseCartesian Therapeutics, Inc.
RNAC
25,208
0.0897%
$17.99$453,616-44.14%
2024-11-18PurchaseCartesian Therapeutics, Inc.
RNAC
58,295
0.2238%
$18.12$1.06M-38.37%
2024-11-15PurchaseCartesian Therapeutics, Inc.
RNAC
277,246
1.0985%
$17.09$4.74M-32.89%
2024-11-14PurchaseCartesian Therapeutics, Inc.
RNAC
96,399
0.3658%
$16.37$1.58M-31.43%
Total: 27
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.